Kadekliman (Dry Extract From Black Cohosh (4,5-8,5:1), Extraction Solvent: Ethanol 60% V/V)

The black cohosh extract in Kadekliman is believed to act on serotonergic pathways and may exhibit weak estrogen‑like activity, influencing the hypothalamic centers that control body temperature and mood, thereby reducing vasomotor and emotional symptoms of menopause.

The appropriate dose of Kadekliman is determined by the prescribing healthcare professional based on individual needs, product formulation, and local regulatory guidance. Patients should follow the dosage instructions provided by their clinician or the product label.

Safety of black cohosh during pregnancy has not been established, and its use is generally discouraged. For breastfeeding women, data are limited; therefore, it is recommended to consult a healthcare provider before using Kadekliman while nursing.

To order Kadekliman, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Kadekliman is an herbal option that differs from hormone replacement therapy (HRT) by not containing synthetic hormones. While HRT directly replaces estrogen, black cohosh may provide symptom relief through indirect modulation of hormonal pathways, offering a non‑hormonal alternative for women who cannot or prefer not to use HRT.

Kadekliman should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, excessive heat, and direct sunlight to maintain product stability.

Kadekliman is taken orally, typically as a tablet or capsule, according to the dosage prescribed by a healthcare professional. It should be swallowed with water and taken with or without food as directed on the label or by the prescriber.

Serious risks, though rare, include potential liver injury, severe allergic reactions such as anaphylaxis, and significant changes in blood pressure. Users should seek immediate medical attention if they experience jaundice, unexplained abdominal pain, swelling, difficulty breathing, or sudden hypertension.

Kadekliman should be avoided by individuals who are pregnant, have known liver disease, are taking anticoagulant therapy, have hormone‑sensitive conditions (e.g., certain cancers), or have a documented allergy to black cohosh. Consultation with a healthcare provider is essential before starting the product.